452 related articles for article (PubMed ID: 8558853)
1. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
2. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
4. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
Nawrocki B; Polette M; Burlet H; Birembaut P; Adnet JJ
J Bone Miner Res; 1999 Feb; 14(2):288-94. PubMed ID: 9933484
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
7. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
Das SK; Yano S; Wang J; Edwards DR; Nagase H; Dey SK
Dev Genet; 1997; 21(1):44-54. PubMed ID: 9291579
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
11. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
12. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Webster L; Chignell AH; Limb GA
Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
[TBL] [Abstract][Full Text] [Related]
14. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig.
Menino AR; Hogan A; Schultz GA; Novak S; Dixon W; Foxcroft GH
Dev Genet; 1997; 21(1):68-74. PubMed ID: 9291582
[TBL] [Abstract][Full Text] [Related]
15. Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone-implant interface of aseptically loosened joint arthroplasties in situ.
Pap T; Pap G; Hummel KM; Franz JK; Jeisy E; Sainsbury I; Gay RE; Billingham M; Neumann W; Gay S
J Rheumatol; 1999 Jan; 26(1):166-9. PubMed ID: 9918259
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
17. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
[TBL] [Abstract][Full Text] [Related]
20. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
